Dr Reddys Laboratories (RDY) Receivables - Net (2017 - 2025)
Dr Reddys Laboratories (RDY) has 8 years of Receivables - Net data on record, last reported at $966.9 million in Q1 2024.
- For Q1 2024, Receivables - Net rose 9.66% year-over-year to $966.9 million; the TTM value through Mar 2024 reached $966.9 million, up 9.66%, while the annual FY2024 figure was $970.0 million, 7.36% up from the prior year.
- Receivables - Net reached $966.9 million in Q1 2024 per RDY's latest filing, up from $881.8 million in the prior quarter.
- Across five years, Receivables - Net topped out at $966.9 million in Q1 2024 and bottomed at $682.4 million in Q1 2021.
- Average Receivables - Net over 5 years is $827.5 million, with a median of $881.8 million recorded in 2023.
- Peak YoY movement for Receivables - Net: decreased 4.95% in 2021, then soared 30.21% in 2022.
- A 5-year view of Receivables - Net shows it stood at $718.0 million in 2020, then dropped by 4.95% to $682.4 million in 2021, then skyrocketed by 30.21% to $888.6 million in 2022, then decreased by 0.77% to $881.8 million in 2023, then grew by 9.66% to $966.9 million in 2024.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $966.9 million in Q1 2024, $881.8 million in Q1 2023, and $888.6 million in Q1 2022.